Nov 15 (Reuters) - Maia Biotechnology Inc MAIA.A :
* MAIA BIOTECHNOLOGY - ON NOV 10, JOSEPH MCGUIRE AND MIHAIL
OBROCEA WERE TERMINATED FROM THEIR POSITIONS AS CFO AND CHIEF
MEDICAL OFFICER RESPECTIVELY
* MAIA BIOTECHNOLOGY- ON NOV 10, CO APPOINTED JEFFREY
HIMMELREICH
AS ITS HEAD OF FINANCE AND PRINCIPAL FINANCIAL AND ACCOUNTING
OFFICER
* MAIA BIOTECHNOLOGY INC: SUSPENDED SALES OF ITS COMMON
STOCK
PURSUANT TO THAT CERTAIN SALES AGREEMENT DATED SEPT 1, BETWEEN
CO & THINKEQUITY
* MAIA BIOTECHNOLOGY INC: CO PROVIDED NOTICE TO THINKEQUITY
THAT
IT IS TERMINATING SALES AGREEMENT WHICH WILL BE EFFECTIVE 10
DAYS AFTER NOV 15, 2023
* MAIA BIOTECHNOLOGY: ON NOV 14, NYSE AMERICAN SAID BELIEVES
CO IS
NOT IN COMPLIANCE WITH CONTINUED LISTING STANDARDS RELATING TO
STOCKHOLDERS’ EQUITY
Further company coverage: MAIA.A
((Reuters.Briefs@thomsonreuters.com;))